Company Overview

Development Stage

About the Company

[Summary] 潮徽生物是一家护理产品研发商,集个人护理、家居护理等领域研发、生产、销售及服务于一体。

演生潮(北京)生物科技有限公司成立于2022年5月6日,基于祁海教授在体液免疫领域近30年序贯研究的原创发现与FIC靶点,针对现有自身免疫以及炎症免疫领域“药物有效性差、复发率高、副作用大、作用人群受众窄、需长期持续用药”等核心痛点与临床未满足需求,结合相关领域医师科学家的长期合作与临床样本分析验证,以免疫类疾病中*核心的致病性细胞与关键调控分子为靶点药物研发的全新医药企业。在此基础上,演生潮源自祁海教授团队的核心方法学(即,对人源细胞体外验证的各种实验体系与各类全新优化的模拟人类免疫疾病的动物模型),可以快速发现、迭代、验证候选的小分子药物或大分子抗体药物,以期完成FIRST-IN-CLASS的药物研发。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

演生潮 Financing History (3 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 数亿人民币
  • Investor: 凯辉基金,国开科创,启明创...

演生潮 Recruitment Overview / Current Status (2 open positions)

Manage
Note: How fast is hiring at 演生潮(北京)生物科技有限公司 growing? . A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

演生潮 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

演生潮 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 865.7998万(元)
Legal Representative: 王毅峰
Date Established:
Credit Code: 91110114MA7MY5RW2Y
Registered Address: 北京市昌平区生命科学园医科路9号院4号楼三层303-299(集群注册)

People who follow 演生潮 also follow

演生潮 Competitors (Similar Companies)

基因合成 生物科技/生物工程 试剂 分子生物学
“一家拥有70余年辉煌历史的制药企业”
医药 生物医药 新药研发 CRO
“Large-scale pharmaceutical distribution enterprise”
制药/药业 医药 药物研发 新药研发
“Although the processing is complicated, we dare not save labor; althou”
“Building a world-class hospital and leading the reform of the healthca”
生命科学 生物信息 分子育种 心血管疾病检测
酵母 动物营养 动物食品 兽医
“Core Mission: Safeguarding Human Health with Life Sciences”
“Life Sciences and Integrated Medicine”
手术器械 骨科医疗器械 医疗器械 3D打印
生物科技/生物工程 医药 生命科学 生命科学研究
诊断试剂 CRO 试剂 分子生物学
临床医学 心血管药 药物研发 医学研究

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates